Optimize Production and Purification in AAV Manufacturing
Adeno-associated viral (AAV) vectors are invaluable tools for the delivery of life-saving genetic and recombinant protein drugs. Yet, their purification poses several production challenges and can require multiple costly steps.
Workflows featuring multiple AAV purification steps can risk product loss and can waste valuable production time. However, by optimizing the upstream production and downstream purification of AAV vector particles, biopharmaceutical companies can overcome these common manufacturing challenges.
This webinar highlights the latest ways to maximize productivity in your AAV manufacturing workflow using affinity chromatography methods.
Watch this webinar to discover: